Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic adipose-derived mesenchymal stem cells for draining fistulas in hidradenitis suppurativa
2024-516595-15-00Phase 2Suspended
- Sponsor
- Red Andaluza de Terapias Avanzadas
- Start
- Nov 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of allogeneic adipose-derived adult mesenchymal stem cells in hidradenitis suppurativa (HS) (2 arms), sponsored by Red Andaluza de Terapias Avanzadas. Primary endpoints: Safety and Combined remission of the treated draining fistula. Started Nov 2024; status: suspended.
02
Drugs
allogeneic adipose-derived adult mesenchymal stem cells
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on 2024-516595-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516595-15-00.